This is the first edition of this guideline. Minor amendments were made to the guideline in July 2008.
Obstetric conditions associated with the need for blood transfusion may lead to morbidity and mortality if not managed correctly. The increasingly important issues in blood transfusion are adverse events associated with transfusion, including potential infection and potential transmission of prions, rising costs and the possible future problems of availability. Unfortunately, information from randomised controlled trials to inform best practice is largely unavailable in the discipline of blood transfusion. The aim of this guideline is to offer guidance about the appropriate use of blood products that neither compromises the affected woman nor exposes her to unnecessary risk. Strategies to maximise the haemoglobin (Hb) level at delivery as well as to minimise blood loss are also discussed. It is envisaged that this guideline will be incorporated into a protocol for each unit to disseminate locally.
This guideline is available to download as a pdf by clicking the link below.